ICC Labs Receives Two Medicinal Cannabis Licenses in Colombia | CashCropToday
0 Shares 145 Views

ICC Labs Receives Two Medicinal Cannabis Licenses in Colombia

February 28, 2018
145 Views

On February 27, 2018, ICC Labs Inc. (TSX-V:ICC) announced that the Ministry of Justice and Law of the Republic of Colombia had granted ICC Labs’ Colombian subsidiary a license to cultivate psychoactive cannabis plants for medicinal purposes for domestic and international distribution.

The Ministry of Health of the Republic of Colombia also granted ICC Labs’ Colombian subsidiary a license to manufacture cannabis derivatives for medicinal purposes. Each license will be valid for a period of five years and may be renewed upon request within three months of expiration.

ICC expects to commence with the construction of a 124,000 sq. ft. greenhouse within the next 30 days, where it will grow psychoactive cannabis plants with 20% THC content for medicinal purposes. The company expects to produce between 8,000 and 12,000 kg of dried psychoactive cannabis flowers during its initial year of production, with quantities increasing upon the establishment of its full production cycle.

In addition, in accordance with the company’s previously announced licenses for non-psychoactive cannabis production, ICC expects to commence growing cannabis strains with at least 15% CBD at an outdoor location within Colombia.

ICC now operates in two South American countries – Colombia and Uruguay.  Between both countries, the company will have a total outdoor acreage available for CBD-strain production of 680 acres and a total greenhouse area for THC-strain production expected to reach 200,000 sq. ft. In addition, ICC is currently building an extraction laboratory in the free trade zone “Science Park” located in Canelones, Uruguay, which will have an expected processing throughput of 150,000 kilograms of dried flowers per year.  Furthermore, the International Board for the Control of Narcotics (at the U.N.) recently assigned Colombia a quota equal to 44% of the global medicinal cannabis production authorized by the board.

ICC will be seeking to take advantage of this situation in order to export cannabis derivatives for medicinal purposes to legal markets throughout the world, such as Canada and Germany

You may be interested

VividGro, a Pegasus Capital Advisors Portfolio Company,  Announces Partnership with Merida Capital Partners
Market Watch
134 views
Market Watch
134 views

VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital Partners

Editor - August 17, 2018

Partnership to Focus on Growth in Horticultural and Cannabis Industries VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has…

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million
Market Watch
243 views
Market Watch
243 views

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million

Editor - August 15, 2018

Harborside, a California based cannabis dispensary brand with multiple locations, is planning the reverse takeover of Canadian public company Lineage Grow Company Ltd. (CSE: BUDD). Lineage is…

The City of Los Angeles Has Begun Accepting Applications for Cannabis Licenses
Politics
326 views
Politics
326 views

The City of Los Angeles Has Begun Accepting Applications for Cannabis Licenses

Editor - August 15, 2018

At the beginning of this month, the city of Los Angeles finally decided to start accepting license applications from cannabis growers, manufacturers, and testing labs. Although marijuana was…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: